Thyroid Dysfunction in Patients Admitted in Cardiac Care Unit: Prevalence, Characteristic and Hospitalization Outcomes

References

• Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. doi:10.1016/j.jacc.2017.04.052
   PubMed Web of Science ®Google Scholar
• Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin North Am. 2014;43(2):517–528. doi:10.1016/j.ecl.2014.02.005
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Cellular action of thyroid hormone on the heart. Thyroid. 2002;12(6):447–452. doi:10.1089/105072502760143809
   PubMed Web of Science ®Google Scholar
• Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Med Clin North Am. 2012;96(2):257–268. doi:10.1016/j.mcna.2012.01.006
   PubMed Web of Science ®Google Scholar
• Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26(5):704–728. doi:10.1210/er.2003-0033
   PubMed Web of Science ®Google Scholar
• Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab. 2002;87(3):968–974. doi:10.1210/jcem.87.3.8302
   PubMed Web of Science ®Google Scholar
• Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526–534. doi:10.1001/archinte.160.4.526
   PubMed Web of Science ®Google Scholar
• Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–1735. doi:10.1161/CIRCULATIONAHA.106.678326
   PubMed Web of Science ®Google Scholar
• Klein I, Zipes DP, Libby P. Endocrine disorders and cardiovascular disease. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed; 2005:2051–2065.
   Google Scholar
• Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675–1678. doi:10.1001/archinte.164.15.1675
   PubMedGoogle Scholar
• Ruggeri RM, Trimarchi F, Biondi B. L-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice. Eur J Endocrinol. 2017;177(4):R199–R217. doi:10.1530/EJE-17-0321
   PubMed Web of Science ®Google Scholar
• Evangelopoulou ME, Alevizaki M, Toumanidis S, et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? Thyroid. 1999;9(10):973–977. doi:10.1089/thy.1999.9.973
   PubMed Web of Science ®Google Scholar
• Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients*. J Clin Endocrinol Metab. 2000;85(12):4701–4705. doi:10.1210/jcem.85.12.7085
   PubMed Web of Science ®Google Scholar
• Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249–1252. doi:10.1056/NEJM199411103311901
   PubMed Web of Science ®Google Scholar
• Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358(9285):861–865. doi:10.1016/S0140-6736(01)06067-6
   PubMed Web of Science ®Google Scholar
• Rothberger GD, Gadhvi S, Michelakis N, Kumar A, Calixte R, Shapiro LE. Usefulness of serum triiodothyronine (T3) to predict outcomes in patients hospitalized with acute heart failure. Am J Cardiol. 2017;119(4):599–603. doi:10.1016/j.amjcard.2016.10.045
   PubMed Web of Science ®Google Scholar
• Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–293. doi:10.1089/10507250252949405
   PubMed Web of Science ®Google Scholar
• Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab. 2007;92(5):1715–1723. doi:10.1210/jc.2006-1869
   PubMed Web of Science ®Google Scholar
• Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92(6):631–642. doi:10.1016/0002-9343(92)90782-7
   PubMed Web of Science ®Google Scholar
• Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000;132(4):270–278. doi:10.7326/0003-4819-132-4-200002150-00004
   PubMed Web of Science ®Google Scholar
• Su W, Zhao XQ, Wang M, Chen H, Li HW. Low T3 syndrome improves risk prediction of in-hospital cardiovascular death in patients with acute myocardial infarction. J Cardiol. 2018;72(3):215–219. doi:10.1016/j.jjcc.2018.02.013
   PubMed Web of Science ®Google Scholar
• Chang C-Y, Chien Y-J, Lin P-C, Chen C-S, Wu M-Y. Nonthyroidal illness syndrome and hypothyroidism in ischemic heart disease population: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2020;105(8):8. doi:10.1210/clinem/dgaa310
   Web of Science ®Google Scholar
• Iervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167(14):1526–1532. doi:10.1001/archinte.167.14.1526
   PubMedGoogle Scholar
• Welsh KJ, Stolze BR, Yu X, Podsiadlo TR, Kim LS, Soldin SJ. Assessment of thyroid function in intensive care unit patients by liquid chromatography tandem mass spectrometry methods. Clin Biochem. 2017;50(6):318–322. doi:10.1016/j.clinbiochem.2016.11.022
   PubMed Web of Science ®Google Scholar
• Doğan S, Dursun H, Can H, Ellıdokuz H, Kaya D. Long-term assessment of coronary care unit patient profile and outcomes: analyses of the 12-years patient records. Turkish J Med Sci. 2016;46(3):801–806. doi:10.3906/sag-1502-88
   PubMed Web of Science ®Google Scholar
• Alventosa-Zaidin M, Guix Font L, Benitez Camps M, et al. Right bundle branch block: prevalence, incidence, and cardiovascular morbidity and mortality in the general population. Eur J Gen Pract. 2019;25(3):109–115. doi:10.1080/13814788.2019.1639667
   PubMed Web of Science ®Google Scholar
• Clark AL, Goode K, Cleland JGF. The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure. Eur J Heart Fail. 2008;10(7):696–702. doi:10.1016/j.ejheart.2008.05.001
   PubMed Web of Science ®Google Scholar
• Al-Ghamdi MA. Morbidity pattern and outcome of patients admitted in a coronary care unit: a report from a secondary hospital in southern region, Saudi Arabia. J Community Hosp Intern Med Perspect. 2018;8(4):191–194. doi:10.1080/20009666.2018.1500421
   PubMed Web of Science ®Google Scholar
• Abdulaziz Qari F. Thyroid hormone profile in patients with acute coronary syndrome. Iran Red Crescent Med J. 2015;17:7. doi:10.5812/ircmj.26919v2
   Web of Science ®Google Scholar
• Kannan L, Shaw PA, Morley MP, et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ Heart Fail. 2018;11(12):e005266. doi:10.1161/CIRCHEARTFAILURE.118.005266
   PubMed Web of Science ®Google Scholar
• Loh KC, Eng PC. Prevalence and prognostic relevance of sick euthyroid syndrome in a medical intensive care unit.. Ann Acad Med Singapore. 1995;24(6):802–806.
   PubMedGoogle Scholar
• Bouthoorn S, Valstar GB, Gohar A, et al. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis. Diabetes Vasc Dis Res. 2018;15(6):477–493. doi:10.1177/1479164118787415
   PubMed Web of Science ®Google Scholar
• Akintoye E, Briasoulis A, Egbe A, et al. National trends in admission and in-hospital mortality of patients with heart failure in the United States (2001–2014). J Am Heart Assoc. 2017;6(12):12. doi:10.1161/JAHA.117.006955
   Web of Science ®Google Scholar
• Ten Haaf ME, Bax M, Ten Berg JM, et al. Sex differences in characteristics and outcome in acute coronary syndrome patients in the Netherlands. Netherlands Hear J. 2019;27(5):263–271. doi:10.1007/s12471-019-1271-0
   PubMed Web of Science ®Google Scholar
• Kindermann M. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28(21):2686. doi:10.1093/eurheartj/ehm379
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2017;177(4):251–259. doi:10.1530/EJE-17-0321
   Web of Science ®Google Scholar
• Hasdai D. Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes. Eur Heart J. 2000;85(12):623–629. doi:10.1210/jcem.85.12.7085
   Google Scholar
• Soeiro A, Araújo VA, Vella JP, et al. Is there any relationship between TSH levels and prognosis in acute coronary syndrome? Arq Bras Cardiol. 2000;132(4):113–118. doi:10.7326/0003-4819-132-4-200002150-00004
   Web of Science ®Google Scholar
• Åsvold BO, Bjøro T, Platou C, Vatten LJ. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT Study in Norway. Clin Endocrinol (Oxf). 2020;105(8):911–917. doi:10.1210/clinem/dgaa310
   Web of Science ®Google Scholar